Vitamin D, Vitamin D Binding Protein and Prostate Cancer Risk in African American Men
Our primary aim is to examine the association between pre-diagnostic vitamin D status, including 25(OH)D, DBP and their molar ratio (a proxy for free or unbound vitamin D) and prostate cancer risk among black men. Our secondary aim is to characterize and compare vitamin D status between black and white men.
The proposed matched nested case-control study will use conditional logistic regression to estimate odds ratios (OR’s) and 95% confidence intervals for the association between vitamin D status and prostate cancer in black males. In addition, descriptive analyses will characterize vitamin D status using data from black and white participants randomized to the prostate cancer screening arm of the parent PLCO study.
Limited information exists on the association between vitamin D status and prostate cancer risk in blacks. Similarly, little is known about racial variation in vitamin D status beyond overall vitamin D concentrations. The PLCO cohort provides rich data that can examine this timely hypothesis specifically among black men using prospectively collected blood samples.
As a key part of my doctoral dissertation research studies, I will use these data to examine the following aims:
Aim 1: Determine whether vitamin D status (including total 25(OH)D, DBP, and the 25(OH)D:DBP molar ratio, a proxy for “free” or unbound 25(OH)D,[1,2]) is associated with prostate cancer risk in black men.
Aim 2: Determine whether there are interactions between DBP and 25(OH)D status and prostate cancer risk in black men. For example, DBP concentrations may moderate the association between circulating 25(OH)D and prostate cancer risk, and vice versa.[3]
Aim 3: Examine concentrations of total 25(OH)D and DBP and the 25(OH)D: DBP molar ratio among blacks and whites to evaluate racial variation in these characteristics.
Sonja Berndt (EBP/OEEB, DCEG)
Barry Graubard (EBP/BB, DCEG)
Stephanie Weinstein (NEB, DCEG)
Demetrius Albanes (NCI)
Tracy Layne (NCI, DCEG, NEB)
-
Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM, Weinstein SJ, Graubard BI, Ma X, Mayne ST, Albanes D
Cancer. 2017 Jul; Volume 123 (Issue 14): Pages 2698-2704 PUBMED -
Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM, Mondul AM, Lindström S, Tsilidis KK, Travis RC, Gerke T, Albanes D, Mucci LA, Giovannucci E, Kraft P, Breast and Prostate Cancer Cohort Consortium Group
Cancer. 2015 Jun 15; Volume 121 (Issue 12): Pages 1949-56 PUBMED